Manufacturer
Concord Biotech
Pharmaceutical manufacturer based in India
Indian manufacturerIndia
- Products listed
- 11
- Molecules
- 4
- Therapy areas
- 1
Concord Biotech is a pharmaceutical manufacturer based in India. MedsAcross lists 11 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- India
- Indian manufacturer
- Yes
- Also listed as
- Concord Biotech Limited
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Concord Biotech products through licensed channels, with the documents your regulator needs.
Immunology and transplant
11 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Mycophenolate 180 mg delayed-release tabletOralGeneric name | Mycophenolate | US FDA | Available on request |
| Mycophenolate 250 mg capsuleOralGeneric name | Mycophenolate | US FDA | Available on request |
| Mycophenolate 360 mg delayed-release tabletOralGeneric name | Mycophenolate | US FDA | Available on request |
| Mycophenolate 500 mg tabletOralGeneric name | Mycophenolate | US FDA | Available on request |
| Tacrolimus 0.5 mg capsuleOralGeneric name | Tacrolimus | US FDA | Available on request |
| Tacrolimus 1 mg capsuleOralGeneric name | Tacrolimus | US FDA | Available on request |
| Tacrolimus 5 mg capsuleOralGeneric name | Tacrolimus | US FDA | Available on request |
| Teriflunomide 14 mg tabletOralGeneric name | Teriflunomide | US FDA | Available on request |
| Teriflunomide 7 mg tabletOralGeneric name | Teriflunomide | US FDA | Available on request |
| Tofacitinib 16.16 mg tabletOralGeneric name | Tofacitinib | US FDA | Available on request |
| Tofacitinib 8.08 mg tabletOralGeneric name | Tofacitinib | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Concord Biotech
Send a request for any of these products. We confirm the licensed source, documents and lead time.